Manufacturing & Supply Chain

Abbott and IDA Ireland announce investment of €10m to fund Sligo site relocation

 Breaking News

Abbott and IDA Ireland announce investment of €10m to fund Sligo site relocation

Abbott and IDA Ireland announce investment of €10m to fund Sligo site relocation
May 31
09:00 2017
Spread the love

Global healthcare company Abbott will relocate its Irish Nutritional Devices business from its existing base at Ballytivnan, Sligo, to a new, purpose-built IDA Ireland Advance Technology building located in the Finisklin industrial estate.

The move will see a combined investment of almost €10 million and will enable the consolidation of manufacturing and business support within one building, enabling the creation of a medical nutrition device centre of excellence. This move also provides space for any additional manufacturing and support positions should they be created by the company in the future.

The aim is for the relocation to be completed in the first half of 2018 following work to extend the Finisklin building. This investment is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.

Sean O’Hara, Abbott’s Site Director at Ballytivnan said: “Our aim is to enable people to live fuller, healthier lives. The talent available in Ireland is key in enabling us to do so. This relocation and investment ensures our people in Sligo can continue to help people all over the world lead healthier lives full of unlimited possibilities.”

CEO of IDA Ireland Martin Shanahan said: “IDA-supported multinational companies contribute significantly to Ireland in terms of direct employment, capital spend and developing Ireland’s skills base. Abbott has a long history of investing in Ireland and valuing the talent and business infrastructure which is available nationally and in the business location of Sligo. Abbott is of key importance to Ireland’s life sciences sector and contributes substantially to Ireland’s export economy. The decision to proactively build properties to attract foreign investors into regional locations has been further evidenced by Abbott Nutrition’s decision to move over 100 existing staff members into the newly built IDA Advance Technology building which will also provide scope for the company to grow in the future.”

The decision to proactively build properties to attract foreign investors into regional locations has been further evidenced by Abbott Nutrition’s decision to move over 100 existing staff members into the newly built IDA Advance Technology building which will also provide scope for the company to grow in the future.

About Author

editor

editor

Related Articles

Follow me on Twitter

New Subscriber

    Subscribe Here



    Advertisements































    National Manufacturing Conference & Exhibition 2020

    NIBRT Springboard Success Stories